Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[There was a higher frequency of CHL1 mRNA decrease in lung squamous cell carcinoma compared to adenocarcinoma (81% vs. 38%, P?=?0.02) without association with tumor progression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP322274.RAeUuOCe1XGWkSISJc8fNpvfEuLDGK48CiQfj2KcgaYIM130_assertion description "[There was a higher frequency of CHL1 mRNA decrease in lung squamous cell carcinoma compared to adenocarcinoma (81% vs. 38%, P?=?0.02) without association with tumor progression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP322274.RAeUuOCe1XGWkSISJc8fNpvfEuLDGK48CiQfj2KcgaYIM130_provenance.
• NP340064.RAgRH-VJ4Z3SVyTGQHEnR6ybVjxH0NMSYCsJmfp7p3YHQ130_assertion description "[There was a higher frequency of CHL1 mRNA decrease in lung squamous cell carcinoma compared to adenocarcinoma (81% vs. 38%, P?=?0.02) without association with tumor progression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP340064.RAgRH-VJ4Z3SVyTGQHEnR6ybVjxH0NMSYCsJmfp7p3YHQ130_provenance.
• NP702143.RAiskcTxmdq3K14uH4z64GZ7XClD5yW_oPLvXuhzAC4OY130_assertion description "[There was a higher frequency of CHL1 mRNA decrease in lung squamous cell carcinoma compared to adenocarcinoma (81% vs. 38%, P?=?0.02) without association with tumor progression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP702143.RAiskcTxmdq3K14uH4z64GZ7XClD5yW_oPLvXuhzAC4OY130_provenance.
• NP508822.RAXoi8ttnhUFgWMgftDzsUXNL4wdAJTVj14PvfM0A7OOI130_assertion description "[There was a higher frequency of CHL1 mRNA decrease in lung squamous cell carcinoma compared to adenocarcinoma (81% vs. 38%, P?=?0.02) without association with tumor progression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP508822.RAXoi8ttnhUFgWMgftDzsUXNL4wdAJTVj14PvfM0A7OOI130_provenance.
• NP733386.RAaerju_I5HJeXOhiumNzObuwrl7dJbzrOwsypy4llkow130_assertion description "[There was a higher frequency of CHL1 mRNA decrease in lung squamous cell carcinoma compared to adenocarcinoma (81% vs. 38%, P?=?0.02) without association with tumor progression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP733386.RAaerju_I5HJeXOhiumNzObuwrl7dJbzrOwsypy4llkow130_provenance.
• NP293075.RALmROMLSWYIzgZVPmGnY2np83rb6de97SbG3KAv5sJyU130_assertion description "[There was a higher frequency of CHL1 mRNA decrease in lung squamous cell carcinoma compared to adenocarcinoma (81% vs. 38%, P?=?0.02) without association with tumor progression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP293075.RALmROMLSWYIzgZVPmGnY2np83rb6de97SbG3KAv5sJyU130_provenance.
• NP345188.RAFW7nZ3SzpJmtptq3Z2_aLnaHVgRvWvPgq5LLn-1i3hE130_assertion description "[There was a higher frequency of CHL1 mRNA decrease in lung squamous cell carcinoma compared to adenocarcinoma (81% vs. 38%, P?=?0.02) without association with tumor progression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP345188.RAFW7nZ3SzpJmtptq3Z2_aLnaHVgRvWvPgq5LLn-1i3hE130_provenance.
• NP351756.RAZjdFB9fSwOUPEP044rAMpu-49gSD5wcPkNCrodPM-pQ130_assertion description "[There was a higher frequency of CHL1 mRNA decrease in lung squamous cell carcinoma compared to adenocarcinoma (81% vs. 38%, P?=?0.02) without association with tumor progression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP351756.RAZjdFB9fSwOUPEP044rAMpu-49gSD5wcPkNCrodPM-pQ130_provenance.
• NP852446.RAbuWYixyX3fFjkYaYww_665Te3RUzNFHnPvQaQlg4LI8130_assertion description "[There was a higher frequency of CHL1 mRNA decrease in lung squamous cell carcinoma compared to adenocarcinoma (81% vs. 38%, P?=?0.02) without association with tumor progression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP852446.RAbuWYixyX3fFjkYaYww_665Te3RUzNFHnPvQaQlg4LI8130_provenance.
• assertion description "[There was a higher frequency of CHL1 mRNA decrease in lung squamous cell carcinoma compared to adenocarcinoma (81% vs. 38%, P?=?0.02) without association with tumor progression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[There was a higher frequency of CHL1 mRNA decrease in lung squamous cell carcinoma compared to adenocarcinoma (81% vs. 38%, P?=?0.02) without association with tumor progression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[There was a higher frequency of CHL1 mRNA decrease in lung squamous cell carcinoma compared to adenocarcinoma (81% vs. 38%, P?=?0.02) without association with tumor progression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP879855.RAfOZ1qpcR4JPN8ibOyHC0uVrczXa7JNhjsf3u0cC-BRI130_assertion description "[There was a higher frequency of CHL1 mRNA decrease in lung squamous cell carcinoma compared to adenocarcinoma (81% vs. 38%, P?=?0.02) without association with tumor progression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP879855.RAfOZ1qpcR4JPN8ibOyHC0uVrczXa7JNhjsf3u0cC-BRI130_provenance.
• NP351777.RAk3T4ihdGkQG_vaq5F23MTjoAq-KeelrzxCeOkY_TcGo130_assertion description "[There was a higher frequency of CHL1 mRNA decrease in lung squamous cell carcinoma compared to adenocarcinoma (81% vs. 38%, P?=?0.02) without association with tumor progression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP351777.RAk3T4ihdGkQG_vaq5F23MTjoAq-KeelrzxCeOkY_TcGo130_provenance.
• NP875431.RAI8R_9PiBNLjFlalzU5n42dKfsSgsaFDmkgVE9U9sKqY130_assertion description "[There was a higher frequency of CHL1 mRNA decrease in lung squamous cell carcinoma compared to adenocarcinoma (81% vs. 38%, P?=?0.02) without association with tumor progression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP875431.RAI8R_9PiBNLjFlalzU5n42dKfsSgsaFDmkgVE9U9sKqY130_provenance.
• NP351776.RA3raTfo-jIrV1CcrTasgshzwb0wnVSWXXJbnnO1EGX44130_assertion description "[There was a higher frequency of CHL1 mRNA decrease in lung squamous cell carcinoma compared to adenocarcinoma (81% vs. 38%, P?=?0.02) without association with tumor progression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP351776.RA3raTfo-jIrV1CcrTasgshzwb0wnVSWXXJbnnO1EGX44130_provenance.
• NP879846.RAL0oREGra-532d25vqTJGBWEtjNsL7as0fAqhM4ewfYo130_assertion description "[There was a higher frequency of CHL1 mRNA decrease in lung squamous cell carcinoma compared to adenocarcinoma (81% vs. 38%, P?=?0.02) without association with tumor progression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP879846.RAL0oREGra-532d25vqTJGBWEtjNsL7as0fAqhM4ewfYo130_provenance.
• NP879849.RAFr2z1FxIE2u0PVmN7oFuilz9eMXR7cL5m_EdJbSgRmE130_assertion description "[There was a higher frequency of CHL1 mRNA decrease in lung squamous cell carcinoma compared to adenocarcinoma (81% vs. 38%, P?=?0.02) without association with tumor progression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP879849.RAFr2z1FxIE2u0PVmN7oFuilz9eMXR7cL5m_EdJbSgRmE130_provenance.
• NP879850.RAJ6QRiuUYOE15ZLdQbzg0bHgMD9d-xhC_6wzMBQzGVc8130_assertion description "[There was a higher frequency of CHL1 mRNA decrease in lung squamous cell carcinoma compared to adenocarcinoma (81% vs. 38%, P?=?0.02) without association with tumor progression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP879850.RAJ6QRiuUYOE15ZLdQbzg0bHgMD9d-xhC_6wzMBQzGVc8130_provenance.
• NP879854.RAFkELp6wxW4tOYU46PrtKLYytkL5f5EKUxMnjicZYBgs130_assertion description "[There was a higher frequency of CHL1 mRNA decrease in lung squamous cell carcinoma compared to adenocarcinoma (81% vs. 38%, P?=?0.02) without association with tumor progression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP879854.RAFkELp6wxW4tOYU46PrtKLYytkL5f5EKUxMnjicZYBgs130_provenance.
• NP852387.RAFPuVgszSJGmO9z0pIITjghqwxRXS9n3_bxuiajGNRA0130_assertion description "[There was a higher frequency of CHL1 mRNA decrease in lung squamous cell carcinoma compared to adenocarcinoma (81% vs. 38%, P?=?0.02) without association with tumor progression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP852387.RAFPuVgszSJGmO9z0pIITjghqwxRXS9n3_bxuiajGNRA0130_provenance.
• NP852441.RAO7kHvm0G68u9Kkm3BO_jc-7SsqYNvNgHcM_XpiaLKlE130_assertion description "[There was a higher frequency of CHL1 mRNA decrease in lung squamous cell carcinoma compared to adenocarcinoma (81% vs. 38%, P?=?0.02) without association with tumor progression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP852441.RAO7kHvm0G68u9Kkm3BO_jc-7SsqYNvNgHcM_XpiaLKlE130_provenance.
• NP879847.RA6lTfGeOg-PJM8agzhqeuG8ELmULS-0iJbVLBMYlj7Ck130_assertion description "[There was a higher frequency of CHL1 mRNA decrease in lung squamous cell carcinoma compared to adenocarcinoma (81% vs. 38%, P?=?0.02) without association with tumor progression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP879847.RA6lTfGeOg-PJM8agzhqeuG8ELmULS-0iJbVLBMYlj7Ck130_provenance.